SlideShare uma empresa Scribd logo
1 de 8
Part III : Ethical Issues in Agriculture and Food Production
Chapter 10. The Patenting of Genes for Agricultural Biotechnology
Keywords: consequentialist; deontological; freedom to operate; intellectual property; justice; monopoly; patent; plant variety; power; TRIPS Chapter 10. The Patenting of Genes for Agricultural Biotechnology
Institutional policy within the major patent jurisdictions supports the legitimacy of plant genes as subject matter, provided that they are part of a truly inventive disclosure.  Chapter 10. The Patenting of Genes for Agricultural Biotechnology
In ethical terms, given that patents do not assign ownership of genes, there does not appear to be a convincing argument that patents are abhorrent when compared with other forms of control of genetic material, e.g. ownership of breeding animals and plants. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
Indeed, the overturning of this aspect of the patenting system would lead to serious consequences for the flow of knowledge into the public domain and for innovation. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
Nevertheless, there are problems based around the ownership of patents by international corporate monopolies (with the attendant centralisation of power and decision-making) but this relates more to market trends and globalisation than anything ethically unsound in patenting per se. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
However, the balancing of intellectual property rights between new scientific knowledge and indigenous knowledge remains problematic. Chapter 10. The Patenting of Genes for Agricultural Biotechnology

Mais conteúdo relacionado

Semelhante a Ethical Issues of Gene Patenting in Agriculture

Breeding and protecting, Symposium Dutch Patent Centre / Plant Variety Office
Breeding and protecting, Symposium Dutch Patent Centre / Plant Variety OfficeBreeding and protecting, Symposium Dutch Patent Centre / Plant Variety Office
Breeding and protecting, Symposium Dutch Patent Centre / Plant Variety OfficeTjeerd Overdijk
 
Biotechnology project
Biotechnology project Biotechnology project
Biotechnology project ArhamReza1
 
Intellectual property rights (2)
Intellectual property rights (2)Intellectual property rights (2)
Intellectual property rights (2)9033955713
 
The Case Of Incyte Genomics
The Case Of Incyte GenomicsThe Case Of Incyte Genomics
The Case Of Incyte Genomicsjrstorella
 
BIOTECHNOLOGY PATENTS – STATUS OF PROTECTION
BIOTECHNOLOGY PATENTS – STATUS OF PROTECTIONBIOTECHNOLOGY PATENTS – STATUS OF PROTECTION
BIOTECHNOLOGY PATENTS – STATUS OF PROTECTIONChiragZala6
 
Accessing other people’s technology for nonprofit research
Accessing other people’s technology for nonprofit researchAccessing other people’s technology for nonprofit research
Accessing other people’s technology for nonprofit researchBhavitha Pulaparthi
 
Material Transfer Agreements
Material Transfer AgreementsMaterial Transfer Agreements
Material Transfer AgreementsMarcel Mongeon
 
Feisee Global Ip Challenges Washington Campus 2010
Feisee Global Ip Challenges Washington Campus 2010Feisee Global Ip Challenges Washington Campus 2010
Feisee Global Ip Challenges Washington Campus 2010lfeisee
 
Accessing other people’s technology for nonprofit
Accessing other people’s technology for nonprofitAccessing other people’s technology for nonprofit
Accessing other people’s technology for nonprofitBhavitha Pulaparthi
 
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...Ioanna Michalopoulou
 
Patenting and regulatory requirements of natural products protection of plant...
Patenting and regulatory requirements of natural products protection of plant...Patenting and regulatory requirements of natural products protection of plant...
Patenting and regulatory requirements of natural products protection of plant...Dr K SUDHEER KUMAR KANDIBANDA
 
pharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptxpharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptxMastewal7
 

Semelhante a Ethical Issues of Gene Patenting in Agriculture (20)

Breeding and protecting, Symposium Dutch Patent Centre / Plant Variety Office
Breeding and protecting, Symposium Dutch Patent Centre / Plant Variety OfficeBreeding and protecting, Symposium Dutch Patent Centre / Plant Variety Office
Breeding and protecting, Symposium Dutch Patent Centre / Plant Variety Office
 
Researchpaper
ResearchpaperResearchpaper
Researchpaper
 
Biotechnology project
Biotechnology project Biotechnology project
Biotechnology project
 
Explaining the benefits of human genome patent
Explaining the benefits of human genome patentExplaining the benefits of human genome patent
Explaining the benefits of human genome patent
 
Intellectual property rights (2)
Intellectual property rights (2)Intellectual property rights (2)
Intellectual property rights (2)
 
Gene patenting
Gene patentingGene patenting
Gene patenting
 
The Case Of Incyte Genomics
The Case Of Incyte GenomicsThe Case Of Incyte Genomics
The Case Of Incyte Genomics
 
BIOTECHNOLOGY PATENTS – STATUS OF PROTECTION
BIOTECHNOLOGY PATENTS – STATUS OF PROTECTIONBIOTECHNOLOGY PATENTS – STATUS OF PROTECTION
BIOTECHNOLOGY PATENTS – STATUS OF PROTECTION
 
Accessing other people’s technology for nonprofit research
Accessing other people’s technology for nonprofit researchAccessing other people’s technology for nonprofit research
Accessing other people’s technology for nonprofit research
 
160804_AWP_WISE16GeneDrive
160804_AWP_WISE16GeneDrive160804_AWP_WISE16GeneDrive
160804_AWP_WISE16GeneDrive
 
Material Transfer Agreements
Material Transfer AgreementsMaterial Transfer Agreements
Material Transfer Agreements
 
Feisee Global Ip Challenges Washington Campus 2010
Feisee Global Ip Challenges Washington Campus 2010Feisee Global Ip Challenges Washington Campus 2010
Feisee Global Ip Challenges Washington Campus 2010
 
Accessing other people’s technology for nonprofit
Accessing other people’s technology for nonprofitAccessing other people’s technology for nonprofit
Accessing other people’s technology for nonprofit
 
To Promote Innovation
To Promote InnovationTo Promote Innovation
To Promote Innovation
 
Feb Biocom panel
Feb Biocom panelFeb Biocom panel
Feb Biocom panel
 
Ipr
IprIpr
Ipr
 
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
 
Patenting and regulatory requirements of natural products protection of plant...
Patenting and regulatory requirements of natural products protection of plant...Patenting and regulatory requirements of natural products protection of plant...
Patenting and regulatory requirements of natural products protection of plant...
 
pharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptxpharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptx
 
QUTGP20151102Patentpremise
QUTGP20151102PatentpremiseQUTGP20151102Patentpremise
QUTGP20151102Patentpremise
 

Mais de Bioetika Fabio Unsoed (13)

T M 1 K O N T R A K P E M B E L A J A R A N 2010
T M 1  K O N T R A K  P E M B E L A J A R A N 2010T M 1  K O N T R A K  P E M B E L A J A R A N 2010
T M 1 K O N T R A K P E M B E L A J A R A N 2010
 
T M 2 P E N D A H U L U A N (2)
T M 2  P E N D A H U L U A N (2)T M 2  P E N D A H U L U A N (2)
T M 2 P E N D A H U L U A N (2)
 
T M 3 Etika Linkungan (1)
T M 3  Etika  Linkungan (1)T M 3  Etika  Linkungan (1)
T M 3 Etika Linkungan (1)
 
T M 4 Etika Linkungan (2)
T M 4  Etika  Linkungan (2)T M 4  Etika  Linkungan (2)
T M 4 Etika Linkungan (2)
 
T M 5 Etika Linkungan (3)
T M 5  Etika  Linkungan (3)T M 5  Etika  Linkungan (3)
T M 5 Etika Linkungan (3)
 
T M 6 Etika Linkungan (4)
T M 6  Etika  Linkungan (4)T M 6  Etika  Linkungan (4)
T M 6 Etika Linkungan (4)
 
T M 7 Etika Linkungan (5)
T M 7  Etika  Linkungan (5)T M 7  Etika  Linkungan (5)
T M 7 Etika Linkungan (5)
 
T M 8 G M O (1)
T M 8  G M O (1)T M 8  G M O (1)
T M 8 G M O (1)
 
T M 9 G M O (2)
T M 9  G M O (2)T M 9  G M O (2)
T M 9 G M O (2)
 
T M 11 G M O (4)
T M 11  G M O (4)T M 11  G M O (4)
T M 11 G M O (4)
 
T M 12 E T I K A M E D I S (1)
T M 12  E T I K A  M E D I S (1)T M 12  E T I K A  M E D I S (1)
T M 12 E T I K A M E D I S (1)
 
T M 13 E T I K A M E D I S (2)
T M 13  E T I K A  M E D I S (2)T M 13  E T I K A  M E D I S (2)
T M 13 E T I K A M E D I S (2)
 
T M 14 E T I K A M E D I S (3)
T M 14  E T I K A  M E D I S (3)T M 14  E T I K A  M E D I S (3)
T M 14 E T I K A M E D I S (3)
 

Ethical Issues of Gene Patenting in Agriculture

  • 1. Part III : Ethical Issues in Agriculture and Food Production
  • 2. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
  • 3. Keywords: consequentialist; deontological; freedom to operate; intellectual property; justice; monopoly; patent; plant variety; power; TRIPS Chapter 10. The Patenting of Genes for Agricultural Biotechnology
  • 4. Institutional policy within the major patent jurisdictions supports the legitimacy of plant genes as subject matter, provided that they are part of a truly inventive disclosure. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
  • 5. In ethical terms, given that patents do not assign ownership of genes, there does not appear to be a convincing argument that patents are abhorrent when compared with other forms of control of genetic material, e.g. ownership of breeding animals and plants. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
  • 6. Indeed, the overturning of this aspect of the patenting system would lead to serious consequences for the flow of knowledge into the public domain and for innovation. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
  • 7. Nevertheless, there are problems based around the ownership of patents by international corporate monopolies (with the attendant centralisation of power and decision-making) but this relates more to market trends and globalisation than anything ethically unsound in patenting per se. Chapter 10. The Patenting of Genes for Agricultural Biotechnology
  • 8. However, the balancing of intellectual property rights between new scientific knowledge and indigenous knowledge remains problematic. Chapter 10. The Patenting of Genes for Agricultural Biotechnology

Notas do Editor

  1. Keywords: consequentialist; deontological; freedom to operate; intellectual property; justice; monopoly; patent; plant variety; power; TRIPS Summary Institutional policy within the major patent jurisdictions supports the legitimacy of plant genes as subject matter, provided that they are part of a truly inventive disclosure. In ethical terms, given that patents do not assign ownership of genes, there does not appear to be a convincing argument that patents are abhorrent when compared with other forms of control of genetic material, e.g. ownership of breeding animals and plants. Indeed, the overturning of this aspect of the patenting system would lead to serious consequences for the flow of knowledge into the public domain and for innovation. Nevertheless, there are problems based around the ownership of patents by international corporate monopolies (with the attendant centralisation of power and decision-making) but this relates more to market trends and globalisation than anything ethically unsound in patenting per se. However, the balancing of intellectual property rights between new scientific knowledge and indigenous knowledge remains problematic.